CRISPR Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...
CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors
In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day.
MarketWatch22h
E-Mini Nasdaq 100 Index Continuous Contract
2-Year U.S. Treasury Note Continuous Contract $102.898 0.012 0.01% 5-Year U.S. Treasury Note Continuous Contract $106.578 0.078 0.07% 10-Year U.S. Treasury Note Continuous Contract $109.172 0.141 ...
MarketWatch11h
Alphabet Inc. Cl C
Spotify Technology S.A. 1.51% $104.03B ...